Quality-of-life outcomes in oncology.
QOL outcomes have become an integral component of many clinical oncology trials. Much work has been performed testing the validity and reliability of Q OL instruments. The current challenge is to understand better the clinical relevance of QOL research in oncology. QOL studies should focus on phase III trials with clear hypotheses that can lead to clinically meaningful interventions.
Siddiqui
Farzan
F
Department of Radiation Oncology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, and Department of Radiation Oncology, Boston University Medical Center, MA, USA.
Kachnic
Lisa A
LA
Movsas
Benjamin
B
D017326:Clinical Trials, Phase III as Topic / Q000379:methods / Q000639:trends; D023381:Endpoint Determination / Q000379:methods / Q000639:trends; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000639:trends; D009369:Neoplasms / Q000628:therapy*; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000639:trends; D010506:Periodicals as Topic; D039781:PubMed; D011788:Quality of Life